ARTICLE | Clinical News
SuliXen: Phase I started
February 4, 2008 8:00 AM UTC
Lipoxen began a Russian Phase I trial in 12 healthy volunteers to compare 0.11 U/kg and 0.31 U/kg SuliXen vs. 0.21 U/kg Lantus insulin glargine from sanofi-aventis Group (Euronext:SAN; NYSE:SNY, Par...